| scholarly article | Q13442814 |
| P356 | DOI | 10.1001/ARCHPSYC.1990.01810240026005 |
| P698 | PubMed publication ID | 2244795 |
| P2093 | author name string | M Tohen | |
| M T Tsuang | |||
| C M Waternaux | |||
| P433 | issue | 12 | |
| P407 | language of work or name | English | Q1860 |
| P1104 | number of pages | 6 | |
| P304 | page(s) | 1106-1111 | |
| P577 | publication date | 1990-12-01 | |
| P1433 | published in | JAMA Psychiatry | Q635830 |
| P1476 | title | Outcome in Mania. A 4-year prospective follow-up of 75 patients utilizing survival analysis | |
| P478 | volume | 47 |
| Q43540831 | 15-year outcome of treated bipolar disorder |
| Q37242709 | 3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder |
| Q36589730 | A longitudinal pilot proton MRS investigation of the manic and euthymic states of bipolar disorder |
| Q52932623 | A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. |
| Q50734803 | A novel scale for measuring mixed states in bipolar disorder. |
| Q77793806 | A relapse prevention group for patients with bipolar and substance use disorders |
| Q34237178 | A review of bipolar disorder in adults |
| Q34176007 | A review of psychosocial outcome in patients with bipolar disorder |
| Q47731766 | Abnormal sleep duration associated with hastened depressive recurrence in bipolar disorder. |
| Q34205852 | Adolecsent mania, EEG abnormality and response to anticonvulsants: a three - year follow-up study |
| Q33761273 | Affective reactivity in response to criticism in remitted bipolar disorder: a laboratory analog of Expressed Emotion |
| Q41710837 | Alcohol problems and long-term psychosocial outcome in Chinese patients with bipolar disorder |
| Q35142739 | Alternatives to lithium and divalproex in the maintenance treatment of bipolar disorder |
| Q37608023 | American tertiary clinic-referred bipolar II disorder versus bipolar I disorder associated with hastened depressive recurrence |
| Q52547106 | Are patients with bipolar affective disorder socially disadvantaged? A comparison with a control group. |
| Q48793990 | Aripiprazole plus divalproex for recently manic or mixed patients with bipolar I disorder: a 6-month, randomized, placebo-controlled, double-blind maintenance trial |
| Q26798232 | Assessment and treatment of mood disorders in the context of substance abuse |
| Q35073763 | Atypical antipsychotics and mood stabilization in bipolar disorder |
| Q35958311 | Behavioral therapies for co-occurring substance use and mood disorders. |
| Q82235766 | Bipolar disorder |
| Q36165238 | Bipolar disorder and health-related quality of life : review of burden of disease and clinical trials |
| Q26795404 | Bipolar disorder in women |
| Q34052830 | Bipolar disorder therapeutics: maintenance treatment |
| Q37165573 | Bipolar disorders: treatment options and patient satisfaction |
| Q51866940 | Bipolar patients in community mental health centers and specialized units. Could they be pooled? |
| Q48939203 | Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder |
| Q33651671 | Characteristics and psychosocial problems of patients with bipolar disorder at high risk for suicide attempt |
| Q34434112 | Circadian rhythms, multilevel models of emotion and bipolar disorder--an initial step towards integration? |
| Q34547113 | Clinical correlates of therapeutic response in bipolar disorder |
| Q48526330 | Clinical definitions of sensitisation in affective disorder: a case register study of prevalence and prediction |
| Q41819650 | Cognition and the differential diagnosis of schizophrenia |
| Q34188361 | Cognitive-behavioral therapy: applications for the management of bipolar disorder |
| Q38584955 | Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: a systematic review and network meta-analysis. |
| Q44859562 | Confusing clinical presentations and differential diagnosis of bipolar disorder |
| Q40866452 | Continuation and maintenance pharmacotherapy for unipolar and bipolar mood disorders. |
| Q35154704 | Costs of bipolar disorder |
| Q34340583 | Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study |
| Q71993596 | Differences and similarities in mixed and pure mania |
| Q57612992 | Differential features between bipolar I and bipolar II disorder |
| Q38873763 | Disparities in Treatment and Service Utilization Among Hispanics and Non-Hispanic Whites with Bipolar Disorder. |
| Q79951368 | Do benzodiazepines extend the duration of follow-up treatment in patients with bipolar disorder? |
| Q34253113 | Drug abuse and bipolar disorder: comorbidity or misdiagnosis? |
| Q35762573 | Early determinants of four-year clinical outcomes in bipolar disorder with psychosis |
| Q36360718 | Early improvement of psychotic symptoms with lithium monotherapy as a predictor of later response in mania |
| Q38591224 | Early interventions for youths at high risk for bipolar disorder: a developmental approach |
| Q35135894 | Ecologically valid support for the link between cognitive and psychosocial functioning in bipolar disorder |
| Q34128935 | Effects of cannabis use on age at onset in schizophrenia and bipolar disorder |
| Q44783760 | Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: secondary analyses of a double-blind, placebo-controlled, randomized clinical trial |
| Q35999567 | Efficacy of atypical antipsychotics in bipolar disorder |
| Q38012647 | Efficacy of pharmacotherapy in bipolar disorder: a report by the WPA section on pharmacopsychiatry |
| Q41743347 | Eight-month functional outcome from mania following a first psychiatric hospitalization |
| Q34370458 | Emerging options in the treatment of bipolar disorders |
| Q33271753 | Enhanced relapse prevention for bipolar disorder--ERP trial. A cluster randomised controlled trial to assess the feasibility of training care coordinators to offer enhanced relapse prevention for bipolar disorder |
| Q33526859 | Excessive substance use in bipolar disorder is associated with impaired functioning rather than clinical characteristics, a descriptive study |
| Q89586706 | Executive functioning but not IQ or illness severity predicts occupational status in bipolar disorder |
| Q40744586 | Family-focused treatment of bipolar disorder: 1-year effects of a psychoeducational program in conjunction with pharmacotherapy |
| Q41860725 | Four year follow-up of first episode manic patients. |
| Q73922848 | Frequencies of signs and symptoms in mixed and pure episodes of mania: implications for the study of manic episodes |
| Q34057133 | Functional impairment and cognition in bipolar disorder |
| Q60445477 | General health and well-being in outpatients with depressive and bipolar disorders |
| Q51066517 | Group cognitive behavioral therapy for bipolar disorder: a feasibility and effectiveness study. |
| Q26824955 | Guideline for treatment of bipolar disorder by the Japanese Society of Mood Disorders, 2012 |
| Q53527476 | Health-related quality of life using the SF-36 in patients with bipolar disorder compared with patients with chronic back pain and the general population. |
| Q33920209 | Historical perspectives and natural history of bipolar disorder |
| Q33355808 | Identifying patterns in treatment response profiles in acute bipolar mania: a cluster analysis approach |
| Q60628033 | Impact of clinical variables on illness time course in mood disorders |
| Q33938089 | Impact of substance abuse on the course and treatment of bipolar disorder |
| Q39264714 | Impaired endoplasmic reticulum stress response in bipolar disorder: cellular evidence of illness progression |
| Q92058586 | Improving Functioning, Quality of Life, and Well-being in Patients With Bipolar Disorder |
| Q25256727 | Influence of postpartum onset on the course of mood disorders |
| Q24243177 | Interventions for helping people recognise early signs of recurrence in bipolar disorder |
| Q24246887 | Interventions for helping people recognise early signs of recurrence in bipolar disorder |
| Q73625619 | Latency and episodes before treatment: response to lithium maintenance in bipolar I and II disorders |
| Q53588055 | Levels of functioning and well-being in recovered psychotic versus nonpsychotic mania. |
| Q92026328 | Lifetime Psychotic Symptoms, Subthreshold Depression and Cognitive Impairment as Barriers to Functional Recovery in Patients with Bipolar Disorder |
| Q41366608 | Lifetime eating disorder comorbidity associated with delayed depressive recovery in bipolar disorder |
| Q57471124 | Lithium, valproate, and carbamazepine prescribing patterns for long-term treatment of bipolar I and II disorders: A prospective study |
| Q41177967 | Long term treatment of bipolar disorder |
| Q36327271 | Long-term remission and recovery in bipolar disorder: a review |
| Q80587525 | Longitudinal research on bipolar disorders |
| Q34180785 | Longitudinal trajectories and associated baseline predictors in youths with bipolar spectrum disorders |
| Q44464135 | Maintenance efficacy of divalproex in the prevention of bipolar depression |
| Q34106695 | Maintenance therapies for classic and other forms of bipolar disorder |
| Q92206076 | Mania in elderly people |
| Q36069919 | Multi-state outcome analysis of treatments (MOAT): application of a new approach to evaluate outcomes in longitudinal studies of bipolar disorder |
| Q72040937 | Negative symptoms in the course of first-episode affective psychosis |
| Q34768572 | Neurocognitive function in bipolar disorder: a comparison between bipolar I and II disorder and matched controls |
| Q45841968 | Number of manic episodes is associated with elevated DNA oxidation in bipolar I disorder |
| Q33673618 | Olanzapine is superior to lamotrigine in the prevention of bipolar depression: a naturalistic observational study. |
| Q34543895 | On the periodicity of manic-depressive insanity, by Eliot Slater (1938): translated excerpts and commentary |
| Q36327250 | Predictive effects of previous episodes on the risk of recurrence in depressive and bipolar disorders |
| Q50884870 | Predictors of recurrence in affective disorder. A case register study. |
| Q35142081 | Predictors of response to treatment in children and adolescents with mood disorders |
| Q45335276 | Predictors of service utilization in veterans with bipolar disorder: a prospective study |
| Q58190181 | Preface |
| Q51998117 | Preliminary evidence of the reliability and validity of the prospective life-chart methodology (LCM-p). |
| Q34108441 | Prevalence and description of psychotic features in bipolar mania |
| Q37810898 | Preventative strategies for early-onset bipolar disorder: towards a clinical staging model |
| Q51959383 | Principles of effectiveness trials and their implementation in VA Cooperative Study #430: 'Reducing the efficacy-effectiveness gap in bipolar disorder'. |
| Q22252279 | Prodromes, coping strategies and psychological interventions in bipolar disorders |
| Q51947193 | Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness. |
| Q33768245 | Psychosocial interventions for bipolar disorder |
| Q36630487 | Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program |
| Q35613754 | Psychotic bipolar disorders: dimensionally similar to or categorically different from schizophrenia? |
| Q37402290 | Randomised controlled trial of efficacy of teaching patients with bipolar disorder to identify early symptoms of relapse and obtain treatment |
| Q38138487 | Recent advances in sleep-wake cycle and biological rhythms in bipolar disorder |
| Q71868722 | Recovery and Relapse in Adolescents with Bipolar Affective Illness: A Five-Year Naturalistic, Prospective Follow-up |
| Q37954423 | Refractoriness in bipolar disorder: definitions and evidence-based treatment |
| Q34196019 | Response of carbamzepine in bipolar disorder: kindlers versus non-kindlers. |
| Q51872425 | Risk of rehospitalization among bipolar disorder patients who are nonadherent to antipsychotic therapy after hospital discharge. |
| Q64072908 | Role of personality disorder in randomised controlled trials of pharmacological interventions for adults with mood disorders: a protocol for a systematic review and meta-analysis |
| Q48777412 | Signs and symptoms of mania in pure and mixed episodes |
| Q51952975 | Skating to where the puck is going to be: a plan for clinical trials and translation research in mood disorders. |
| Q36070600 | Sleep matters: sleep functioning and course of illness in bipolar disorder |
| Q33665575 | Sleep, illness course, and concurrent symptoms in inter-episode bipolar disorder |
| Q40452049 | Substance abuse and the chronically mentally ill: a description of dual diagnosis treatment services in a psychiatric hospital. |
| Q51917536 | Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area sample. |
| Q28076486 | The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines |
| Q53657532 | The Maudsley bipolar disorder project. Clinical characteristics of bipolar disorder I in a Catchment area treatment sample. |
| Q60643065 | The McLean–Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis |
| Q34108582 | The ability of lithium and other mood stabilizers to decrease suicide risk and prevent relapse |
| Q52044411 | The collaborative practice model for bipolar disorder: design and implementation in a multi-site randomized controlled trial. |
| Q37292350 | The contemporary face of bipolar illness: complex diagnostic and therapeutic challenges. |
| Q34042216 | The course of bipolar disorder in rural India |
| Q44331411 | The effect of episodes on recurrence in affective disorder: a case register study |
| Q34232208 | The effect of personalized guideline-concordant treatment on quality of life and functional impairment in bipolar disorder |
| Q30494370 | The emerging modern face of mood disorders: a didactic editorial with a detailed presentation of data and definitions |
| Q29306635 | The impact of substance abuse on the course of bipolar disorder |
| Q47450065 | The initial prodrome to bipolar affective disorder: prospective case studies |
| Q30656863 | The neuropsychology and neuroanatomy of bipolar affective disorder: a critical review |
| Q36170788 | The phenotypes of bipolar disorder: relevance for genetic investigations |
| Q21203517 | The prevalence and significance of substance use disorders in bipolar type I and II disorder |
| Q33619910 | The psychopathology and treatment of bipolar disorder |
| Q33786604 | The relationship between religious involvement and clinical status of patients with bipolar disorder |
| Q73727431 | The relatively good prognosis of bipolar disorders in a Turkish bipolar clinic |
| Q40656919 | The significance of psychotic features in manic episodes: a report from the NIMH collaborative study |
| Q90054109 | Toward clinical digital phenotyping: a timely opportunity to consider purpose, quality, and safety |
| Q41837093 | Treatment Guidelines in Bipolar Disorders and the Importance of Proper Clinical Trial Design |
| Q54643814 | Treatment-latency and previous episodes: relationships to pretreatment morbidity and response to maintenance treatment in bipolar I and II disorders. |
| Q30928632 | What is the impact of genome-wide supported risk variants for schizophrenia and bipolar disorder on brain structure and function? A systematic review |
| Q92189038 | What is the optimal serum level for lithium in the maintenance treatment of bipolar disorder? A systematic review and recommendations from the ISBD/IGSLI Task Force on treatment with lithium |
| Q79905002 | [Prognostic aspects of bipolar disorders] |
| Q57698064 | Évolution du trouble bipolaire |
Search more.